Sphenopalatine Ganglion Block in Septorhinoplasty

Istanbul Medeniyet University

Status: Completed

Conditions: Pain, Postoperative; Rhinoplasty

Treatments: Procedure: Sphenopalatine Ganglion Block

Study type: Observational

Funder types: Other

Identifiers

NCT06157970

MedeniyetUniverstySAkbulut001

Details and patient eligibility

About

Septorhinoplasty is a widely performed surgery that aims to correct both functional and aesthetic problems of the nose. Despite its expected clinical benefits, septorhinoplasty surgery causes postoperative pain, which affects the patient's functional recovery and satisfaction. Opioids, Non-steroidal anti-inflammatory drugs (NSAII), acetaminophen and local anesthetics are used in peroperative pain management in septorhinoplasty. Sphenopalatine ganglion block (SPGB), which has been recently described and has different application areas, is a regional analgesia technique that has been investigated for this purpose. Although there are studies on postoperative pain in septorhinoplasty surgeries, there are not enough studies on its effects on intraoperative pain.

This study may have positive effects on appropriate pain management, patient comfort and surgical outcomes as multimodal analgesia management in septorhinoplasty surgeries, and may make significant contributions to evidence-based practices.

Enrollment: 50 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Undergoing septorhinoplasty surgery
• Ages between 18-65
• ASA (American Society of Anesthesiologists) score I-II

Exclusion criteria

• Unavailable postoperative pain scores and analgesic use in the hospital registry system
• Local anesthetic drug allergy and toxicity
• Advanced organ failure
• Mental retardation

Patients who are pregnant

Trial design

50 participants in 2 patient groups

Block Group

Description:

After intubation, the plastic part of the 18G angioket is placed transnasally into both nostrils in the supine position of the patients who will undergo sphenopalatine ganglion block, with the head in 15-20° extension and is advanced until it contacts the posterior mucosa. After contact, withdraw 1 mm and apply 0.5% bupivacaine 2 ml by dropping into the postnasal space within 1 minute.

Treatment:

Procedure: Sphenopalatine Ganglion Block

Control Group

Description:

Group of patients who did not undergo sphenopalatine gangion block